Mazdutide activates two receptor pathways. In research models, GLP-1 receptor activation is studied for hypothalamic appetite-signaling and gastric-motility pathways. Glucagon receptor activation is studied for hepatic glycogenolysis, energy-expenditure signaling, and lipid-oxidation pathways via upregulation of CPT1a and other beta-oxidation enzymes in vitro. The combined receptor engagement is studied as a dual mechanism not achieved by GLP-1-only or GLP-1/GIP compounds.
Mazdutide — Dual GLP-1/Glucagon Receptor Agonist Research Peptide
A dual GLP-1/glucagon receptor agonist peptide studied for metabolic-regulation, energy-metabolism, and hepatic lipid-oxidation pathways in preclinical and in-vitro models.
CAS 2382390-26-7 • 4,476 g/mol • Prepared for research use • Per research workflow
Mazdutide Structure
Reference identifiers are batch-specific for coded materials and are documented on the lot COA/SDS rather than inferred or estimated.
Mechanism of Action
Mazdutide Overview
Mazdutide is a dual-acting peptide that targets both GLP-1 and glucagon receptors simultaneously. It represents a distinct pharmacological approach from other incretin-based compounds: while po-s01 targets GLP-1 alone and po-s02 pairs GLP-1 with GIP, mazdutide combines GLP-1 with glucagon receptor activation. The glucagon component is what differentiates mazdutide mechanistically. In preclinical and in-vitro models, glucagon receptor activation is studied for hepatic lipid-oxidation pathways, energy-expenditure signaling, and receptor-mediated lipolysis pathways. This makes mazdutide of interest as a research tool that engages metabolic signaling from both sides — GLP-1-receptor pathways alongside glucagon-receptor pathways. Mazdutide has been characterized in preclinical and in-vitro studies for dual GLP-1 and glucagon receptor activity and its associated effects on lipid-metabolism and hepatic lipid-oxidation pathways at the receptor level. The hepatic lipid-oxidation pathway is a particular focus of study, as glucagon receptor activation is associated with fat-oxidation signaling in hepatic models. PharmaOrder offers mazdutide as a lyophilized research peptide with Certificate of Analysis documentation for in-vitro research applications.
Purity & Testing
Mazdutide is listed as 10mg lyophilized vial. Catalog identity: CAS 2382390-26-7; formula C207H317N45O65; molecular weight 4,476 g/mol. The lot COA for Mazdutide is available in your account. Finnrick Analytical performs HPLC purity analysis and mass spectrometry identity confirmation on that lot.
- Catalog configurations: 10mg lyophilized vial
- CAS: 2382390-26-7
- Formula: C207H317N45O65
- Molecular weight: 4,476 g/mol
See the Mazdutide COA page.
Storage & Handling
Store the lyophilized powder at -20°C, protected from light. Bring to room temperature before opening.
Shipping
Ships worldwide from 6 distribution centers via USPS Ground Advantage
Available for direct research purchase
Research-use-only products are sold strictly for laboratory and research purposes. By purchasing, you acknowledge that these products are not intended for human or veterinary use, and you agree to PharmaOrder's RUO terms of service.
Published Research
Selected peer-reviewed studies referenced in this product overview.
FAQ
What is mazdutide?
How is mazdutide different from po-s01?
How is mazdutide different from po-s02?
What has mazdutide shown in published research?
How should mazdutide be stored?
Is mazdutide available for research purchase?
Related Products
AOD-9604
A synthetic peptide fragment of human growth hormone (amino acids 177-191) studied for lipid-metabolism (lipolysis) pathways in vitro.
MOTS-c
A 16-amino-acid peptide encoded in mitochondrial DNA, studied for its role in metabolic homeostasis, exercise-induced stress response, and insulin sensitivity.
PO-S01
A complete 10-vial po-s01 of lyophilized peptide. COA available. For research use only.
Ready to order Mazdutide?
In stock. Ships within 24 hours, with tracking.
Order Now